Good morning :)
$
N

Nasus Pharma Ltd.

NSRX

AMEX
$3.832.18% (+0.08)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Drug Manufacturers - General

Micro Cap

With a market cap of $44.2M the stock is ranked 5155

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

PB
PB

Close price divided by the book value per share at the end of the most recent quarter

4.07
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.11
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

Company Profile

Peers

Peers

P/E Ratio
38.91
38.91
1Y Return
54.93%
54.93%
Buy Reco %
77.41
77.41
P/E Ratio
31.45
31.45
1Y Return
54.94%
54.94%
Buy Reco %
45.83
45.83
P/E Ratio
120.34
120.34
1Y Return
80.62%
80.62%
Buy Reco %
57.69
57.69
P/E Ratio
24.32
24.32
1Y Return
24.58%
24.58%
Buy Reco %
15.38
15.38
P/E Ratio
24.34
24.34
1Y Return
0.43%
0.43%
Buy Reco %
90.00
90.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - General
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Nasus Pharma Ltd. -4.07-
Eli Lilly and Company38.9130.511.12
Johnson & Johnson31.457.694.32

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

-0.6
-1.3
-2.9
-5.9
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ4 2023Q2 2024Q4 2024Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue--------
Net Income-----0.62-1.39-2.97-5.94
Net Profit Margin--------

Frequently asked questions

Frequently asked questions

  1. Nasus Pharma Ltd. (NSRX) share price today is $3.83 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $4.00 and a day low of $3.49.

  2. Nasus Pharma Ltd. stock trades on AMEX under the ticker symbol NSRX.

  3. Nasus Pharma Ltd.'s market capitalization is $44.16M as of September 5, 2026 at 1:30 AM IST.

  4. Nasus Pharma Ltd.'s price-to-earnings (P/E) ratio is N/A as of September 4, 2026.

  5. Nasus Pharma Ltd.'s price-to-book (P/B) ratio is 4.07 as of September 4, 2026.

  6. Yes, You can buy Nasus Pharma Ltd. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Nasus Pharma Ltd. shares in three steps: 1. Search Nasus Pharma Ltd. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Nasus Pharma Ltd. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Nasus Pharma Ltd. (NSRX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.6096 shares at the current price of $3.83.

Loading...